专利检索 ap:("Rutgers, The State University of New Jersey" OR "PhageNova Bio, Inc.") AND inv:"Fenny Tang" 第 1 页

1.

发明公开
ENHANCING IMMUNE RESPONSES THROUGH TARGETED ANTIGEN EXPRESSION 审中-公开

公开(公告)号：US20230241203A1

公开(公告)日：2023-08-03

申请号：US18004517

申请日：2021-07-03

申请人： Rutgers, The State University of New Jersey , PhageNova Bio, Inc.

发明人： Renata Pasqualini , Wadih Arap , Steven Libutti , Christopher Markosian , Daniela Staquicini , Fenny Tang , Tracey Smith , Virginia Yao

IPC分类号： A61K39/215 , A61K45/06 , A61P31/14 , C12N15/86

CPC分类号： A61K39/215 , A61K45/06 , A61P31/14 , C12N15/86 , A61K2039/5256

摘要： The present disclosure includes an immunogenic composition comprising an effective amount of a therapeutic engineered phage and a pharmaceutically acceptable carrier. In certain aspects, the disclosure includes a method of stimulating an immune response in a subject comprising administering to the subject a composition comprising an effective amount of a therapeutic engineered phage. In certain aspects, the disclosure includes a method for treating, ameliorating, and/or preventing a coronavirus infection in a subject comprising administering a composition comprising an effective amount of a therapeutic engineered phage.